Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000623781 | SCV000740545 | uncertain significance | not specified | 2016-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001432207 | SCV001634971 | likely benign | Long QT syndrome | 2024-12-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002438304 | SCV002752477 | likely benign | Cardiovascular phenotype | 2021-09-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003979946 | SCV004791344 | likely benign | AKAP9-related disorder | 2021-02-09 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |